HCTI — Healthcare Triangle Income Statement
0.000.00%
- $9.44m
- $19.51m
- $11.70m
- 37
- 53
- 18
- 28
Annual income statement for Healthcare Triangle, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.3 | 35.3 | 45.9 | 33.2 | 11.7 |
Cost of Revenue | |||||
Gross Profit | 8.59 | 10.5 | 11.3 | 6.78 | 2.89 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.2 | 40.6 | 56.3 | 40.9 | 16.4 |
Operating Profit | 1.18 | -5.36 | -10.4 | -7.7 | -4.75 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.61 | -5.93 | -9.55 | -8.65 | -5.96 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.35 | -5.95 | -9.61 | -8.69 | -5.97 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.35 | -5.95 | -9.61 | -8.69 | -5.97 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.35 | -5.95 | -9.61 | -8.69 | -5.97 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.604 | -2.02 | -2.62 | -1.81 | -1.13 |
Dividends per Share |